
Adeeb Al-Quthami, MD. د/ اديب القثامي
@dr_adeebq
Cardiovascular Imaging | Opinions are my own/not medical advice @BIDPlymouth
ID: 1136058852
31-01-2013 05:07:19
2,2K Tweet
1,1K Followers
1,1K Following




Exploring new horizons in nuclear cardiology – assessing perfusion, physiology and the microcirculation in peripheral arterial disease. A State-of-the-Art Review by Santiago Callegari and Dr. Al Sinusas, Yale Cardiology #cvnuc #PAD #VascularImaging Read now👉bit.ly/43erhVg








📉 Earlier is better: Vutrisiran works across ATTR-CM stages, but the biggest survival gains come in early disease. Time is myocardium. jacc.org/doi/10.1016/j.… #JACC #HELIOSB #ATTRCM #Vutrisiran #Amyloidosis mathew.maurer Ronald Witteles



Excited to have participated in this #Delphi study for the management of 🫀#sarcoidosis, just published in JACC Journals. Covers lots of controversial topics in #sarcoid management. sciencedirect.com/science/articl…


Treat the valve AND the myocardium when facing severe AS+amyloidosis. Both AVR and tafamidis independently ↓ mortality Dual therapy=best outcomes w/ similar survival to lone AS+AVR. Dual pathology is common (~13%) warranting RCT. tinyurl.com/2zmpht8x Bravo Thomas Treibel! 👏🏻


Who develops ⬇️LVEF during exercise despite No CAD or a hypertensive response? Are they an early subphenotype of HFpEF? Mayo Clinic CV📝finds pts(3/4 women)w SOB/CP & exercise-induced ⬇️in LVEF w WMA (in 4/5)on ESE & NO CAD have high incidence of HF🏥& AF bit.ly/3FwR4jB




Left ventricular myocardium-to-blood ratio >1.5 on 99mTc-HMDP SPECT/CT accurately detects ATTR-CM University of Helsinki #cvnuc #amyloidosis. Editorial by Dominik C. Benz Unispital_USZ & Sarah Cuddy Brigham and Women's Hospital Read now👉bit.ly/3IdNYSp



Chief, Division of Cardiology, Department of Medicine, Upstate Medical University #NewProfilePic
